HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monica Herrera Selected Research

Interleukin-6 (Interleukin 6)

2/2021CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.
5/2020Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monica Herrera Research Topics

Disease

4COVID-19
02/2021 - 05/2020
2Viremia
02/2021 - 05/2020
2Inflammation (Inflammations)
02/2021 - 05/2020
1Post-Acute COVID-19 Syndrome
01/2021
1Infections
01/2021
1Pneumonia (Pneumonitis)
05/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
05/2020
1Disease Progression
04/2016
1Empyema
02/2014
1Syncope (Fainting)
06/2008

Drug/Important Bio-Agent (IBA)

2CCR5 Receptors (CCR5 Receptor)IBA
02/2021 - 05/2020
2leronlimabIBA
02/2021 - 05/2020
2RNA (Ribonucleic Acid)IBA
02/2021 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
02/2021 - 05/2020
1CytokinesIBA
02/2021
1Viral RNAIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Chemokine CCL5IBA
05/2020
1galactomannanIBA
04/2016
1polyglucosanIBA
04/2016
1Indicators and Reagents (Reagents)IBA
04/2016
1Cefepime (Maxipime)FDA LinkGeneric
02/2014
1Levofloxacin (Levaquin)FDA Link
02/2014
1carbapenemaseIBA
02/2014
1A-factor (Streptomyces)IBA
06/2008

Therapy/Procedure

1Aftercare (After-Treatment)
02/2021
1Therapeutics
05/2020
1Artificial Respiration (Mechanical Ventilation)
05/2020